A rare earth upconversion energy transfer nanosensing platform, construction method and application

By using amino-modified nucleic acid aptamers combined with rare earth upconversion luminescent nanoparticles in fluorescence resonance energy transfer technology, a rare earth upconversion energy transfer nanosensing platform was constructed, solving the background fluorescence interference and low signal-to-noise ratio. Problem, high sensitivity and stability of target detection is achieved.

CN113640269BActive Publication Date: 2024-11-19NINGBO INST OF MATERIALS TECH & ENG CHINESE ACAD OF SCI
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202111018090.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-09-01
Publication Date
2024-11-19
Estimated Expiration
2041-09-01

AI Technical Summary

Technical Problem

The existing fluorescence resonance energy transfer technology has problems of background fluorescence interference and low signal-to-noise ratio under ultraviolet-visible light excitation, and the preparation of inorganic nanoacceptors is complex and unstable, which affects the reliability of the detection signal.

Method used

The amino-modified nucleic acid aptamer is combined with rare earth up-converted luminescent nanoparticles, and the polydopamine fluorescent receptor material is assembled through π-π interaction to build a rare earth up-converted energy transfer nanosensing platform, and use near-infrared excitation sources to reduce optics Interfere and improve energy transfer efficiency.

Benefits of technology

The signal-to-noise ratio and sensitivity of the detection are significantly improved, the stability and efficiency of the detection signal are ensured, and the target molecules can be analyzed highly sensitively in complex samples.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN113640269B_ABST
    Figure CN113640269B_ABST
Patent Text Reader

Abstract

The present invention discloses a rare earth up-conversion energy transfer nanosensing platform, a construction method and an application. The rare earth up-conversion energy transfer nanosensing platform comprises: an amino-modified nucleic acid aptamer; a fluorescent donor material, one end of the nucleic acid aptamer is covalently modified on the surface of the fluorescent donor material; and a fluorescent acceptor material, the fluorescent donor material modified with the nucleic acid aptamer is assembled on the surface of the fluorescent acceptor material through π-π interaction; wherein the fluorescent donor material is a rare earth up-conversion luminescent material, and the fluorescent acceptor material is polydopamine. The fluorescent acceptor polydopamine used in the present invention has the advantages of simple preparation, uniform size, good water solubility, and excellent fluorescence quenching performance. It can effectively quench up-conversion luminescence and has a higher quenching efficiency, thereby improving the detection sensitivity. The detection of the target using the constructed rare earth up-conversion energy transfer nanosensing platform has a higher signal-to-noise ratio and sensitivity.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a rare earth up-conversion energy transfer nanosensing platform and a construction method thereof, as well as application of the platform in target detection, and belongs to the technical field of spectral application. Background Art

[0002] Fluorescence resonance energy transfer (FRET) is a highly sensitive, high spatial resolution, non-destructive homogeneous detection technology that combines fluorescence spectroscopy with resonance energy transfer technology. FRET refers to the transfer of donor excited state energy to the acceptor in a non-radiative form due to dipole-dipole interaction when the fluorescence donor and acceptor are in the range of 1-10nm and the emission spectrum of the donor overlaps with the absorption spectrum of the acceptor. This technology has been applied in the field of analytical chemistry for more than 40 years. While it is constantly improving itself, it has greatly promoted the development of biomedical analysis.

[0003] However, as a spectral technique, FRET has certain limitations. For example, when the fluorescent donor is excited by ultraviolet-visible light, it will cause interference between the background fluorescence and scattered light in the sample. In addition, when the fluorescence excitation spectra of the donor and the acceptor overlap, both will be excited at the same time. To solve the above problems, rare earth upconversion luminescent nanoparticles (UCPs) with near-infrared excitation characteristics are used as energy donors in FRET technology. Under near-infrared light excitation, the optical interference in the matrix is ​​eliminated, and the signal-to-noise ratio or sensitivity is significantly improved. Since energy transfer is easy to occur only on the surface or at the luminescent center very close to the surface of UCPs, the energy transfer efficiency is usually not high (less than 30%) when organic dyes are used as fluorescent acceptors. In recent years, inorganic nanoreceptors, such as graphene oxide, carbon nanoparticles, nanogold and polyaniline, have a very high molar extinction coefficient, which can break through the FRET distance limitation, greatly quench the luminescence of UCPs, and improve the energy transfer efficiency. However, these nanoreceptors usually or partially have problems such as complex preparation, uneven morphology or size, and unstable colloids, which lead to problems such as complex FRET construction process and unstable detection signal. Summary of the invention

[0004] The main purpose of the present invention is to provide a rare earth up-conversion energy transfer nanosensing platform and a construction method thereof, so as to overcome some of the shortcomings of the existing up-conversion fluorescence resonance energy transfer technology.

[0005] Another object of the present invention is to provide application of the rare earth upconversion energy transfer nanosensing platform in target detection.

[0006] In order to achieve the above-mentioned invention object, the technical solution adopted by the present invention includes:

[0007] The embodiment of the present invention provides a rare earth up-conversion energy transfer nanosensing platform, which includes:

[0008] Amino-modified nucleic acid aptamers;

[0009] A fluorescence donor material, one end of the nucleic acid aptamer is covalently modified on the surface of the fluorescence donor material;

[0010] A fluorescent acceptor material, wherein the fluorescent donor material modified with a nucleic acid aptamer is assembled on the surface of the fluorescent acceptor material through π-π interaction;

[0011] Wherein, the fluorescent donor material is a rare earth up-conversion luminescent material, and the fluorescent acceptor material is polydopamine.

[0012] Furthermore, the nucleic acid aptamer is a high-affinity, selected nucleic acid molecule corresponding to the target molecule, and the target includes any one or a combination of two or more of antibiotic targets, mycotoxins, small biological molecules, protein targets, silver ions, etc., but is not limited thereto.

[0013] The embodiment of the present invention also provides a method for constructing the rare earth up-conversion energy transfer nanosensing platform, which comprises:

[0014] Providing amino-modified nucleic acid aptamers;

[0015] Providing a fluorescence donor material, and covalently coupling and modifying the nucleic acid aptamer to the surface of the fluorescence donor material;

[0016] A fluorescent acceptor material is provided, and a coupled and modified fluorescent donor material is mixed with the fluorescent acceptor material until the fluorescence of the fluorescent donor material is quenched, thereby establishing a rare earth up-conversion energy transfer nanosensing platform.

[0017] The embodiment of the present invention also provides the application of the rare earth up-conversion energy transfer nanosensing platform in the field of target detection.

[0018] Compared with the prior art, the advantages of the present invention include:

[0019] 1) The method for constructing the rare earth upconversion energy transfer nanosensing platform provided by the present invention is to covalently couple the nucleic acid aptamer to the surface of the fluorescent donor material, and mix the fluorescent donor material coupled with the nucleic acid aptamer with the polydopamine fluorescent acceptor material. Because the hydrophobic region of the single-stranded nucleic acid and the surface of the polydopamine will undergo π-π interaction self-assembly, the distance between the fluorescent donor and the acceptor is shortened, energy transfer and quenching of the upconversion luminescence occur, thereby constructing the rare earth upconversion energy transfer nanosensing platform. When a specific target is present, the target molecule has a stronger affinity with the aptamer, and the combination will cause a conformational change, thereby moving the luminophore away from the polydopamine receptor, and the upconversion luminescence is restored. Since the excitation source of this technology is near-infrared light (980nm), it can well overcome optical interferences such as background fluorescence and scattered light, improve detection sensitivity, and can be directly applied to high-sensitivity analysis of targets in complex sample matrices;

[0020] 2) The preparation process of the polydopamine fluorescent receptor used in the present invention is quite simple, the size is uniform and adjustable, and the surface has abundant functional groups such as hydroxyl and amino groups. It has the advantages of simple preparation, uniform size, good water solubility, and excellent fluorescence quenching performance. It can effectively quench upconversion luminescence, and the detection of the target using the constructed rare earth upconversion energy transfer nanosensor platform has a higher signal-to-noise ratio and sensitivity. More importantly, compared with the above-mentioned nanoreceptors, research data show that the light absorption performance of polydopamine is more excellent. At the same concentration, the rare earth upconversion energy transfer nanosensor platform based on polydopamine nanoreceptors will have a higher quenching efficiency, thereby improving the detection sensitivity. In addition, the excellent size uniformity, colloidal stability and water solubility of polydopamine can ensure that the detection signal is more stable. BRIEF DESCRIPTION OF THE DRAWINGS

[0021] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments recorded in the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0022] Figure 1 It is a schematic diagram of a rare earth up-conversion energy transfer nanosensing platform and chloramphenicol detection in a typical embodiment of the present invention;

[0023] Figure 2 is a transmission electron microscopy (TEM) photograph of the rare earth up-conversion NaYF4:Yb.Er in Example 1 of the present invention;

[0024] Figure 3 is a transmission electron microscopy (TEM) photograph of the polydopamine nanoparticles in Example 1 of the present invention;

[0025] Figure 4 It is a fluorescence quenching spectrum diagram of up-conversion luminescent particles modified with nucleic acid aptamers by polydopamine nanoparticles of different concentrations in a typical embodiment of the present invention;

[0026] Figure 5 This is a graph of the upconversion fluorescence recovery spectrum caused by the rare earth upconversion fluorescence resonance energy transfer system and the addition of different concentrations of chloramphenicol in a typical embodiment of the present invention. DETAILED DESCRIPTION

[0027] The technical solution of the present invention will be explained in more detail below. However, it should be understood that within the scope of the present invention, the above-mentioned technical features of the present invention and the technical features specifically described below (such as in the embodiments) can be combined with each other to form a new or preferred technical solution. Due to space limitations, they will not be described one by one here.

[0028] In view of the deficiencies in the prior art, the inventors of this case have proposed the technical solution of the present invention after long-term research and extensive practice, which is mainly: covalently coupling the nucleic acid aptamer to the surface of the fluorescent donor material, mixing the fluorescent donor material coupled with the nucleic acid aptamer with the polydopamine fluorescent acceptor material, because the hydrophobic region of the single-stranded nucleic acid and the surface of the polydopamine will undergo π-π interaction self-assembly, so that the distance between the fluorescent donor and the acceptor is shortened, energy transfer occurs, and quenching of upconversion luminescence occurs, thereby constructing the rare earth upconversion energy transfer nanosensing platform. The technical solution, its implementation process and principle, etc. will be further explained in conjunction with the accompanying drawings as follows.

[0029] One aspect of an embodiment of the present invention provides a rare earth upconversion energy transfer nanosensing platform (also referred to as an "upconversion fluorescence resonance energy transfer system") comprising:

[0030] Amino-modified nucleic acid aptamers;

[0031] A fluorescence donor material, one end of the nucleic acid aptamer is covalently modified on the surface of the fluorescence donor material;

[0032] A fluorescent acceptor material, wherein the fluorescent donor material modified with a nucleic acid aptamer is assembled on the surface of the fluorescent acceptor material through π-π interaction;

[0033] Wherein, the fluorescent donor material is a rare earth up-conversion luminescent material, and the fluorescent acceptor material is polydopamine.

[0034] Furthermore, the fluorescent donor material is rare earth up-conversion luminescent nanoparticles, and the particle size thereof is 20 to 60 nm.

[0035] Furthermore, the fluorescent receptor material is polydopamine nanoparticles, and the particle size thereof is 50 to 200 nm.

[0036] Furthermore, the mass ratio of the fluorescent donor material to the fluorescent acceptor material is 1:1 to 1:10.

[0037] Furthermore, the molar ratio of the fluorescent donor material to the nucleic acid aptamer is 1000:1 to 5000:1.

[0038] In some embodiments, the nucleic acid aptamer can be a high-affinity, selected nucleic acid molecule corresponding to any target molecule, and the target can be any one or a combination of two or more of antibiotic targets (such as chloramphenicol), mycotoxins (such as aflatoxin, ochratoxin, etc.), small biological molecules (such as adenosine triphosphate, cysteine, etc.), protein targets (such as thrombin), silver ions, etc., but is not limited thereto.

[0039] Another aspect of the embodiments of the present invention further provides a method for constructing a rare earth up-conversion energy transfer nanosensing platform, which comprises:

[0040] Providing amino-modified nucleic acid aptamers;

[0041] Providing a fluorescence donor material, and covalently coupling and modifying the nucleic acid aptamer to the surface of the fluorescence donor material;

[0042] A fluorescent acceptor material is provided, and a coupled and modified fluorescent donor material is mixed with the fluorescent acceptor material until the fluorescence of the fluorescent donor material is quenched, thereby establishing a rare earth up-conversion energy transfer nanosensing platform.

[0043] In some embodiments, the construction method specifically includes:

[0044] providing a first buffer solution,

[0045] The first buffer solution, the fluorescent donor material and the coupling agent are mixed to obtain a first reaction liquid, and the mixture is collected by centrifugation to obtain a first upper layer liquid;

[0046] The first upper layer liquid is mixed with the second buffer solution, and nucleic acid aptamers are added to obtain a second reaction solution, which is then collected by centrifugation to obtain a second upper layer liquid.

[0047] Furthermore, the mass ratio of the fluorescent donor material to the fluorescent acceptor material is 1:1 to 1:10.

[0048] Furthermore, the molar ratio of the fluorescent donor material to the nucleic acid aptamer is 1000:1 to 5000:1.

[0049] Furthermore, the mass ratio of the fluorescent donor material to the coupling agent is 1-10:2-20.

[0050] In some embodiments, the construction method further comprises:

[0051] The second upper layer liquid is mixed with the fluorescent acceptor material until the fluorescence of the fluorescent donor material is quenched, thereby establishing a rare earth up-conversion energy transfer nanosensing platform.

[0052] As a more typical implementation case, the method for constructing the rare earth upconversion energy transfer nanosensing platform includes the following steps:

[0053] Step S1: covalently coupling the nucleic acid aptamer to the surface of the fluorescent donor material;

[0054] Step S2: providing a label-free fluorescent receptor material;

[0055] Step S3: Mixing the fluorescent donor material coupled with the nucleic acid aptamer with the label-free fluorescent acceptor material until the fluorescence of the fluorescent donor material is quenched, thereby obtaining the rare earth up-conversion energy transfer nanosensing platform.

[0056] In some embodiments, the step S1 of covalently coupling the nucleic acid aptamer to the surface of the fluorescent donor material comprises the following steps:

[0057] Step S1-1: providing a first buffer solution;

[0058] Step S1-2: adding a fluorescent donor material and a coupling agent in a mass ratio of (1-10): (2-20) to the first buffer solution to obtain a first reaction solution;

[0059] Step S1-3: centrifugally separating the first reaction liquid and collecting the first upper layer liquid;

[0060] Step S1-4: adding the first upper layer liquid to the second buffer solution, and adding amino-modified nucleic acid aptamer (0.5-5 OD) to obtain a second reaction solution;

[0061] Step S1-5: Centrifuge the second reaction liquid to obtain the second upper layer of liquid, and store it in a refrigerator at 4 degrees Celsius for later use.

[0062] Furthermore, in step S1, the fluorescent donor material is rare earth up-conversion luminescent nanoparticles.

[0063] Furthermore, in step S1, the nucleic acid aptamer can be a high-affinity, specific nucleic acid molecule corresponding to any target molecule, and the target can be any one or a combination of two or more of antibiotic targets (such as chloramphenicol), mycotoxins (such as aflatoxin, ochratoxin, etc.), small biological molecules (such as adenosine triphosphate, cysteine, etc.), protein targets (such as thrombin), silver ions (Ag(I) ions), etc., but are not limited thereto.

[0064] Furthermore, in step S2, the fluorescent receptor material is polydopamine nanoparticles.

[0065] Furthermore, in step S1-1, the first buffer solution is a 2-(N-morpholino)ethanesulfonic acid (MES) solution, and the pH value of the MES buffer solution is 4.5 to 7.0, and the concentration is 10 to 100 mmol / L.

[0066] Furthermore, in step S1-2, the coupling agent is 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC.HCL), N-hydroxysulfosuccinimide (Sulfo-NHS), etc., but is not limited thereto.

[0067] Furthermore, in step S1-4, the second buffer solution is a HEPES (4-hydroxyethylpiperazineethanesulfonic acid) solution, and the pH value of the HEPES buffer solution is 6.8 to 9.5, and the concentration is 10 to 100 mmol / L.

[0068] In some embodiments, in step S2, the method for preparing polydopamine nanoparticles comprises the following steps:

[0069] adding dopamine to a mixed solvent of ethanol and water, and stirring vigorously to obtain a third reaction solution;

[0070] Add concentrated aqueous ammonia (the volume of which is 0.2-2% of the mixed solvent) to the third reaction solution, and continue stirring and reacting at room temperature for 24 hours to obtain a fourth reaction solution;

[0071] Centrifuging the fourth reaction liquid to collect the bottom precipitate;

[0072] The precipitate is washed with pure water and then ultrasonically dispersed in an aqueous solution to obtain the polydopamine nanoparticles.

[0073] Furthermore, the mass ratio of dopamine, ethanol and water is 0.01:3:1 to 0.1:3:1.

[0074] In summary, the preparation process of the polydopamine nanoparticles used in the present invention is quite simple, the size is uniform and adjustable, the surface has abundant functional groups such as hydroxyl groups and amino groups, and the water solubility is excellent. It has the advantages of simple preparation, uniform size, good water solubility, and excellent fluorescence quenching performance, and can effectively quench upconversion luminescence.

[0075] More importantly, compared with the above-mentioned nanoreceptors, research data show that polydopamine has better light absorption performance. At the same concentration, the rare earth upconversion energy transfer nanosensor platform based on polydopamine nanoreceptors will have a higher quenching efficiency, thereby improving the detection sensitivity. In addition, the excellent size uniformity, colloidal stability and water solubility of polydopamine can ensure a more stable detection signal.

[0076] Another aspect of the embodiments of the present invention further provides the application of the aforementioned rare earth up-conversion energy transfer nanosensing platform in the field of target detection.

[0077] Furthermore, the target can be any one or a combination of two or more of antibiotic targets (such as chloramphenicol), mycotoxins (such as aflatoxin, ochratoxin, etc.), small biological molecules (such as adenosine triphosphate, etc.), heavy metal ion targets (such as silver ions, etc.), protein targets (such as thrombin), silver ions, etc., but is not limited thereto.

[0078] Furthermore, the rare earth up-conversion energy transfer nanosensing platform constructed by the present invention has a higher signal-to-noise ratio and sensitivity for target detection.

[0079] In summary, the construction method and mechanism of the rare earth upconversion energy transfer nanosensing platform provided by the present invention are:

[0080] The nucleic acid aptamer is covalently coupled to the fluorescent donor surface, and the fluorescent donor material coupled with the nucleic acid aptamer is mixed with the polydopamine fluorescent acceptor material. Because the hydrophobic region of the single-stranded nucleic acid and the polydopamine surface will undergo π-π interaction self-assembly, the distance between the fluorescent donor and the acceptor is shortened, energy transfer and quenching of up-conversion luminescence occur, thereby constructing the new technology of up-conversion fluorescence resonance energy transfer based on rare earth. When a specific target exists, the target molecule has a stronger affinity with the aptamer, and the combination will cause a conformational change, thereby making the luminophore away from the polydopamine receptor, and the up-conversion luminescence is restored. Since the excitation source of this technology is near-infrared light (980nm), it can well overcome optical interferences such as background fluorescence and scattered light, improve detection sensitivity, and can be directly applied to high-sensitivity analysis of targets in complex sample matrices.

[0081] The technical scheme of the present invention is further described in detail below in conjunction with several preferred embodiments. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all of the embodiments. Based on the embodiments in the present invention, all other embodiments obtained by ordinary technicians in the field without creative work belong to the scope of protection of the present invention. The implementation conditions used in the following embodiments can be further adjusted according to actual needs, and the unspecified implementation conditions are usually the conditions in conventional experiments.

[0082] Example 1 Construction of UCPs-PDA upconversion fluorescence resonance energy transfer system and its antibiotic (eg, chloramphenicol) detection and analysis

[0083] (1) Preparation and water-soluble modification of rare earth upconversion luminescent materials

[0084] An aqueous solution containing 1 mmol Ln(CF3COO)3(Y:Yb:Er=78:20:2) is used as a precursor, octadecene and oleic acid are used as solvents, and heated to 150°C under magnetic stirring to react to form oleic acid rare earth salt, cooled to room temperature, and then methanol (including: NH4F and NaOH) is added to the system, stirred for 0.5h, then heated to 100°C to remove methanol, and then under argon atmosphere, the system temperature is raised to 290°C, reacted for 1.5h, cooled to room temperature, ethanol is added to precipitate, and washed with ethanol 3 times. The precipitate is oil-soluble UCPs. Subsequently, 300 mg of polyacrylic acid (PAA) and 30 ml of diethylene glycol were weighed and nitrogen was passed at 110 degrees until PAA dissolved. After the solution was cooled to 50°C, 100 mg of UCPs (dissolved in 8 ml of toluene) was added, and then the temperature was raised to 100 degrees Celsius, vacuumed, toluene and cyclohexane were removed, and the temperature was kept for 30 minutes, and the temperature was raised to 240 degrees and kept for 2 hours. After cooling to room temperature, the precipitate was washed with ethanol by centrifugation to obtain water-soluble UCPs.

[0085] (2) Covalent coupling of chloramphenicol aptamers and PAA-UCPs

[0086] Weigh 5 mg of PAA-UCPs and dissolve them in 1 ml of MES buffer solution (pH.6.1, 100 mM), then add 10 mg of EDC.HCl and 15 mg of Sulfo-NHS to activate the carboxyl group, and shake at room temperature for 30 minutes. Then, adjust the pH of the reaction solution to 7.4 with a dilute NaOH solution (1 M), add 1 OD of chloramphenicol nucleic acid aptamer (sequence SEQ ID NO: 1: 5'-NH2-C6-ACT TCA GTGAGT TGT CCC ACG GTC GGC GAG TCG GTG GTA G-3'), react for 4 hours, centrifuge, wash with water once, and finally store in HEPES buffer (50 mM, pH: 7.4) and place in a refrigerator at 4 degrees Celsius for use.

[0087] (3) Preparation of polydopamine nanoreceptors

[0088] Weigh 0.2 g of dopamine and dissolve it in 4 ml of water. Then quickly add it to a mixed solvent containing concentrated ammonia (1 ml), ethanol (15 ml) and water (35 ml). Stir vigorously and react at room temperature for 12 hours. Then centrifuge and wash with water 3 times. Dissolve it in water and place it in a refrigerator at 4 degrees Celsius for later use.

[0089] (4) Construction of rare earth upconversion fluorescence resonance energy transfer system and its application in chloramphenicol detection

[0090] EP tubes containing UCPs-nucleic acid aptamer conjugates (5 μg / mL) were arranged in parallel, and then 0, 2, 4, 6, 8, and 10 μg / mL of polydopamine were added. Finally, the volume was fixed to 1.0 ml with HEPES buffer (50 mM, pH: 7.4). After thorough mixing and shaking incubation, the upconversion fluorescence quenching spectrum was measured, and the polydopamine concentration at the maximum quenching efficiency was determined to be 6 μg / ml. Furthermore, UCPs-nucleic acid aptamer conjugates (5 μg / mL) and polydopamine 6 μg / ml were prepared in parallel, and then a series of chloramphenicol solutions with concentrations of 0, 2, 5, 8, 10, 15, 20, 30, and 50 nM were added. Finally, the volume was fixed to 1.0 ml with HEPES buffer (50 mM, pH: 7.4), mixed thoroughly, and incubated with shaking. The upconversion fluorescence recovery spectrum was measured, and a working curve between the chloramphenicol concentration and the luminescence intensity at the strongest emission wavelength of UCPs was established. It was found that the chloramphenicol concentration had a good linear relationship in the range of 2-30 nM, and the detection limit was 0.8 nM.

[0091] Example 2: Construction of UCPs-PDA-based upconversion fluorescence resonance energy transfer system and its detection and analysis of foodborne toxins (such as aflatoxin b1, AFB1)

[0092] (1) Preparation and water-soluble modification of rare earth upconversion luminescent materials

[0093] An aqueous solution containing 1 mmol Ln(CF3COO)3(Y:Yb:Er=78:20:2) is used as a precursor, octadecene and oleic acid are used as solvents, and heated to 150°C under magnetic stirring to react to form oleic acid rare earth salt, cooled to room temperature, and then methanol (including: NH4F and NaOH) is added to the system, stirred for 0.5h, then heated to 100°C to remove methanol, and then under argon atmosphere, the system temperature is raised to 290°C, reacted for 1.5h, cooled to room temperature, ethanol is added to precipitate, and washed with ethanol 3 times. The precipitate is oil-soluble UCPs. Subsequently, 300 mg of polyacrylic acid (PAA) and 30 ml of diethylene glycol were weighed and nitrogen was passed at 110 degrees until PAA dissolved. After the solution was cooled to 50°C, 100 mg of UCPs (dissolved in 8 ml of toluene) was added, and then the temperature was raised to 100 degrees Celsius, vacuumed, toluene and cyclohexane were removed, and the temperature was kept for 30 minutes, and the temperature was raised to 240 degrees and kept for 2 hours. After cooling to room temperature, the precipitate was washed with ethanol by centrifugation to obtain water-soluble UCPs.

[0094] (2) Covalent coupling of AFB1 aptamer and PAA-UCPs

[0095] Weigh 5 mg PAA-UCPs and dissolve them in 1 ml MES buffer solution (pH.6.1, 100 mM), then add 10 mg EDC.HCl and 15 mg Sulfo-NHS to activate the carboxyl group, and shake at room temperature for 30 minutes. Then, adjust the pH of the reaction solution to 7.4 with dilute NaOH solution (1 M), add 1 OD of AFB1 nucleic acid aptamer (sequence SEQ ID NO:2:5'-NH2-C6-GCATCACTACAGTCATTACGCATCGGGTAAGCGGAACTGA-GGAGTGGGAGGTAAATCGTGTGAAGTGCTGTCCC-3'), react for 4 hours, centrifuge, wash with water once, and finally store in HEPES buffer (50 mM, pH: 7.4) and place in a refrigerator at 4 degrees Celsius for use.

[0096] (3) Preparation of polydopamine nanoreceptors

[0097] Weigh 0.2 g of dopamine and dissolve it in 4 ml of water. Then quickly add it to a mixed solvent containing concentrated ammonia (1 ml), ethanol (15 ml) and water (35 ml). Stir vigorously and react at room temperature for 12 hours. Then centrifuge and wash with water 3 times. Dissolve it in water and place it in a refrigerator at 4 degrees Celsius for later use.

[0098] (4) Construction of rare earth upconversion fluorescence resonance energy transfer system and its application in AFB1 detection

[0099] EP tubes containing UCPs-nucleic acid aptamer conjugates (5 μg / mL) were arranged in parallel, and then 0, 2, 4, 6, 8, and 10 μg / mL of polydopamine were added. Finally, the volume was fixed to 1.0 ml with HEPES buffer (50 mM, pH: 7.4). After thorough mixing and shaking incubation, the upconversion fluorescence quenching spectrum was measured to determine that the polydopamine concentration at the maximum quenching efficiency was 4 μg / ml. Furthermore, UCPs-aptamer conjugates (5 μg / mL) and polydopamine 4 μg / ml were prepared in parallel, and then a series of AFB1 solutions with concentrations of 0, 0.2, 0.5, 1, 2, 5, 10, 15, 20, and 30 nM were added. Finally, the volume was fixed to 1.0 ml with HEPES buffer (50 mM, pH: 7.4), mixed thoroughly, and incubated with shaking. The upconversion fluorescence recovery spectrum was measured, and a working curve between the AFB1 concentration and the luminescence intensity at the strongest emission wavelength of UCPs was established. It was found that the AFB1 concentration had a good linear relationship in the range of 0.2-10 nM, and the detection limit was 0.036 nM.

[0100] Example 3: Construction of UCPs-PDA-based upconversion fluorescence resonance energy transfer system and its detection and analysis of foodborne toxins (such as ochratoxin A, OTA)

[0101] (1) Preparation and water-soluble modification of rare earth upconversion luminescent materials

[0102] An aqueous solution containing 1 mmol Ln(CF3COO)3(Y:Yb:Er=78:20:2) is used as a precursor, octadecene and oleic acid are used as solvents, and heated to 150°C under magnetic stirring to react to form oleic acid rare earth salt, cooled to room temperature, and then methanol (including: NH4F and NaOH) is added to the system, stirred for 0.5h, then heated to 100°C to remove methanol, and then under argon atmosphere, the system temperature is raised to 290°C, reacted for 1.5h, cooled to room temperature, ethanol is added to precipitate, and washed with ethanol 3 times. The precipitate is oil-soluble UCPs. Subsequently, 300 mg of polyacrylic acid (PAA) and 30 ml of diethylene glycol were weighed and nitrogen was passed at 110 degrees until PAA dissolved. After the solution was cooled to 50°C, 100 mg of UCPs (dissolved in 8 ml of toluene) was added, and then the temperature was raised to 100 degrees Celsius, vacuumed, toluene and cyclohexane were removed, and the temperature was kept for 30 minutes, and the temperature was raised to 240 degrees and kept for 2 hours. After cooling to room temperature, the precipitate was washed with ethanol by centrifugation to obtain water-soluble UCPs.

[0103] (2) Covalent coupling of OTA aptamers and PAA-UCPs

[0104] Weigh 5 mg of PAA-UCPs and dissolve them in 1 ml of MES buffer solution (pH.6.1, 100 mM), then add 10 mg of EDC.HCl and 15 mg of Sulfo-NHS to activate the carboxyl group, and shake the reaction at room temperature for 30 minutes. Subsequently, adjust the pH of the reaction solution to 7.4 with a dilute NaOH solution (1 M), add 1 OD of OTA nucleic acid aptamer (sequence SEQ ID NO:3:5'-NH2-C6-GATCGGGTGTGGGTGGCGTAAAGGGAGCATCGGACA-3'), react for 4 hours, centrifuge, wash with water once, and finally store in HEPES buffer (50 mM, pH: 7.4) and place in a 4 degree Celsius refrigerator for use.

[0105] (3) Preparation of polydopamine nanoreceptors

[0106] Weigh 0.2 g of dopamine and dissolve it in 4 ml of water. Then quickly add it to a mixed solvent containing concentrated ammonia (1 ml), ethanol (15 ml) and water (35 ml). Stir vigorously and react at room temperature for 12 hours. Then centrifuge and wash with water 3 times. Dissolve it in water and place it in a refrigerator at 4 degrees Celsius for later use.

[0107] (4) Construction of rare earth upconversion fluorescence resonance energy transfer system and its application in OTA detection

[0108] EP tubes containing UCPs-nucleic acid aptamer conjugates (5 μg / mL) were arranged in parallel, and then 0, 2, 4, 6, 8, and 10 μg / mL of polydopamine were added. Finally, the volume was fixed to 1.0 ml with HEPES buffer (50 mM, pH: 7.4). After thorough mixing and shaking incubation, the upconversion fluorescence quenching spectrum was measured, and the polydopamine concentration at the maximum quenching efficiency was determined to be 6 μg / ml. Furthermore, UCPs-aptamer conjugates (5 μg / mL) and polydopamine 4 μg / ml were prepared in parallel, and then a series of OTA solutions with concentrations of 0, 0.2, 0.5, 1, 2, 5, 10, 15, 20, and 30 nM were added. Finally, the volume was fixed to 1.0 ml with HEPES buffer (50 mM, pH: 7.4), mixed thoroughly, and incubated with shaking. The upconversion fluorescence recovery spectrum was measured, and a working curve between the AFB1 concentration and the luminescence intensity at the strongest emission wavelength of UCPs was established. It was found that the OTA concentration had a good linear relationship in the range of 0.5-20 nM, and the detection limit was 0.18 nM.

[0109] Example 4: Construction of UCPs-PDA-based upconversion fluorescence resonance energy transfer system and adenosine triphosphate (ATP) detection and analysis

[0110] (1) Preparation and water-soluble modification of rare earth upconversion luminescent materials

[0111] An aqueous solution containing 1 mmol Ln(CF3COO)3(Y:Yb:Er=78:20:2) is used as a precursor, octadecene and oleic acid are used as solvents, and heated to 150°C under magnetic stirring to react to form oleic acid rare earth salt, cooled to room temperature, and then methanol (including: NH4F and NaOH) is added to the system, stirred for 0.5h, then heated to 100°C to remove methanol, and then under argon atmosphere, the system temperature is raised to 290°C, reacted for 1.5h, cooled to room temperature, ethanol is added to precipitate, and washed with ethanol 3 times. The precipitate is oil-soluble UCPs. Subsequently, 300 mg of polyacrylic acid (PAA) and 30 ml of diethylene glycol were weighed and nitrogen was passed at 110 degrees until PAA dissolved. After the solution was cooled to 50°C, 100 mg of UCPs (dissolved in 8 ml of toluene) was added, and then the temperature was raised to 100 degrees Celsius, vacuumed, toluene and cyclohexane were removed, and the temperature was kept for 30 minutes, and the temperature was raised to 240 degrees and kept for 2 hours. After cooling to room temperature, the precipitate was washed with ethanol by centrifugation to obtain water-soluble UCPs.

[0112] (2) Covalent coupling of ATP aptamers and PAA-UCPs

[0113] Weigh 5 mg of PAA-UCPs and dissolve them in 1 ml of MES buffer solution (pH.6.1, 100 mM), then add 10 mg of EDC.HCl and 15 mg of Sulfo-NHS to activate the carboxyl group, and shake the reaction at room temperature for 30 minutes. Subsequently, adjust the pH of the reaction solution to 7.4 with a dilute NaOH solution (1 M), add 1 OD of ATP nucleic acid aptamer (sequence SEQ ID NO: 4: 5'-NH2-C6-ACCTGGGGGAGTATTGCGGAGGAAGGT-3'), react for 4 hours, centrifuge, wash with water once, and finally store in HEPES buffer (50 mM, pH: 7.4) and place in a refrigerator at 4 degrees Celsius for use.

[0114] (3) Preparation of polydopamine nanoreceptors

[0115] Weigh 0.2 g of dopamine and dissolve it in 4 ml of water. Then quickly add it to a mixed solvent containing concentrated ammonia (1 ml), ethanol (15 ml) and water (35 ml). Stir vigorously and react at room temperature for 12 hours. Then centrifuge and wash with water 3 times. Dissolve it in water and place it in a refrigerator at 4 degrees Celsius for later use.

[0116] (4) Construction of rare earth upconversion fluorescence resonance energy transfer system and its application in ATP detection

[0117] EP tubes containing UCPs-nucleic acid aptamer conjugates (5 μg / mL) were arranged in parallel, and then 0, 2, 4, 6, 8, and 10 μg / mL of polydopamine were added. Finally, the volume was fixed to 1.0 ml with HEPES buffer (50 mM, pH: 7.4). After thorough mixing and shaking incubation, the upconversion fluorescence quenching spectrum was measured, and the polydopamine concentration at the maximum quenching efficiency was determined to be 6 μg / ml. Furthermore, UCPs-aptamer conjugates (5 μg / mL) and polydopamine 6 μg / ml were prepared in parallel, and then a series of ATP solutions with concentrations of 0, 0.05, 0.2, 0.5, 1, 2, 5, 10, 20, and 30 μM were added. Finally, the volume was fixed to 1.0 ml with HEPES buffer (50 mM, pH: 7.4), mixed thoroughly, and incubated with shaking. The upconversion fluorescence recovery spectrum was measured, and a working curve between AFB1 concentration and the luminescence intensity at the strongest emission wavelength of UCPs was established. It was found that the ATP concentration had a good linear relationship in the range of 0.2-20 μM, and the detection limit was 0.04 μM.

[0118] Example 5: Construction of UCPs-PDA-based upconversion fluorescence resonance energy transfer system and its Ag(I) ion detection and analysis

[0119] (1) Preparation and water-soluble modification of rare earth upconversion luminescent materials

[0120] An aqueous solution containing 1 mmol Ln(CF3COO)3(Y:Yb:Er=78:20:2) is used as a precursor, octadecene and oleic acid are used as solvents, and heated to 150°C under magnetic stirring to react to form oleic acid rare earth salt, cooled to room temperature, and then methanol (including: NH4F and NaOH) is added to the system, stirred for 0.5h, then heated to 100°C to remove methanol, and then under argon atmosphere, the system temperature is raised to 290°C, reacted for 1.5h, cooled to room temperature, ethanol is added to precipitate, and washed with ethanol 3 times. The precipitate is oil-soluble UCPs. Subsequently, 300 mg of polyacrylic acid (PAA) and 30 ml of diethylene glycol were weighed and nitrogen was passed at 110 degrees until PAA dissolved. After the solution was cooled to 50°C, 100 mg of UCPs (dissolved in 8 ml of toluene) was added, and then the temperature was raised to 100 degrees Celsius, vacuumed, toluene and cyclohexane were removed, and the temperature was kept for 30 minutes, and the temperature was raised to 240 degrees and kept for 2 hours. After cooling to room temperature, the precipitate was washed with ethanol by centrifugation to obtain water-soluble UCPs.

[0121] (2) Covalent coupling of Ag(I) aptamers and PAA-UCPs

[0122] Weigh 5 mg PAA-UCPs and dissolve them in 1 ml MES buffer solution (pH.6.1, 100 mM), then add 10 mg EDC.HCl and 15 mg Sulfo-NHS to activate the carboxyl group, and shake at room temperature for 30 minutes. Then, adjust the pH of the reaction solution to 7.4 with a dilute NaOH solution (1 M), add 1 OD of Ag (I) nucleic acid aptamer (sequence SEQ ID NO: 5: 5'-NH2-C6-CTCTCTTCTCTTCATTTTTCAACACAACACAC-3'), react for 4 hours, centrifuge, wash with water once, and finally store in HEPES buffer (50 mM, pH: 7.4) and place in a 4 degree Celsius refrigerator for use.

[0123] (3) Preparation of polydopamine nanoreceptors

[0124] Weigh 0.2 g of dopamine and dissolve it in 4 ml of water. Then quickly add it to a mixed solvent containing concentrated ammonia (1 ml), ethanol (15 ml) and water (35 ml). Stir vigorously and react at room temperature for 12 hours. Then centrifuge and wash with water 3 times. Dissolve it in water and place it in a refrigerator at 4 degrees Celsius for later use.

[0125] (4) Construction of rare earth upconversion fluorescence resonance energy transfer system and its application in L-Cys detection

[0126] EP tubes containing UCPs-nucleic acid aptamer conjugates (5 μg / mL) were arranged in parallel, and then 0, 2, 4, 6, 8, and 10 μg / mL of polydopamine were added. Finally, the volume was fixed to 1.0 ml with HEPES buffer (50 mM, pH: 7.4). After thorough mixing and shaking incubation, the upconversion fluorescence quenching spectrum was measured, and the polydopamine concentration at the maximum quenching efficiency was determined to be 8 μg / ml. Furthermore, UCPs-aptamer conjugates (5 μg / mL) and polydopamine 8 μg / ml were prepared in parallel, and then a series of Ag(I) solutions with concentrations of 0, 1, 5, 10, 25, 50, 75, 100, and 200 nM were added. Finally, the volume was fixed to 1.0 ml with HEPES buffer (50 mM, pH: 7.4), mixed thoroughly, and incubated with shaking. The upconversion fluorescence recovery spectrum was measured, and a working curve between the Ag(I) concentration and the luminescence intensity at the strongest emission wavelength of UCPs was established. It was found that the Ag(I) concentration had a good linear relationship in the range of 5.0-75 nM, and the detection limit was 2.7 nM.

[0127] Example 6: Construction of UCPs-PDA-based upconversion fluorescence resonance energy transfer system and its thrombin detection analysis

[0128] (1) Preparation and water-soluble modification of rare earth upconversion luminescent materials

[0129] An aqueous solution containing 1 mmol Ln(CF3COO)3(Y:Yb:Er=78:20:2) is used as a precursor, octadecene and oleic acid are used as solvents, and heated to 150°C under magnetic stirring to react to form oleic acid rare earth salt, cooled to room temperature, and then methanol (including: NH4F and NaOH) is added to the system, stirred for 0.5h, then heated to 100°C to remove methanol, and then under argon atmosphere, the system temperature is raised to 290°C, reacted for 1.5h, cooled to room temperature, ethanol is added to precipitate, and washed with ethanol 3 times. The precipitate is oil-soluble UCPs. Subsequently, 300 mg of polyacrylic acid (PAA) and 30 ml of diethylene glycol were weighed and nitrogen was passed at 110 degrees until PAA dissolved. After the solution was cooled to 50°C, 100 mg of UCPs (dissolved in 8 ml of toluene) was added, and then the temperature was raised to 100 degrees Celsius, vacuumed, toluene and cyclohexane were removed, and the temperature was kept for 30 minutes, and the temperature was raised to 240 degrees and kept for 2 hours. After cooling to room temperature, the precipitate was washed with ethanol by centrifugation to obtain water-soluble UCPs.

[0130] (2) Covalent coupling of thrombin aptamers and PAA-UCPs

[0131] Weigh 5 mg of PAA-UCPs and dissolve them in 1 ml of MES buffer solution (pH.6.1, 100 mM), then add 10 mg of EDC.HCl and 15 mg of Sulfo-NHS to activate the carboxyl group, and shake the reaction at room temperature for 30 minutes. Subsequently, adjust the pH of the reaction solution to 7.4 with a dilute NaOH solution (1 M), add 1 OD of thrombin nucleic acid aptamer (sequence SEQ ID NO: 6: 5'-NH2-C6-ACGGTTGGTGTGGTTGG-3'), react for 4 hours, centrifuge, wash with water once, and finally store in HEPES buffer (50 mM, pH: 7.4) and place in a 4 degree Celsius refrigerator for use.

[0132] (3) Preparation of polydopamine nanoreceptors

[0133] Weigh 0.2 g of dopamine and dissolve it in 4 ml of water. Then quickly add it to a mixed solvent containing concentrated ammonia (1 ml), ethanol (15 ml) and water (35 ml). Stir vigorously and react at room temperature for 12 hours. Then centrifuge and wash with water 3 times. Dissolve it in water and place it in a refrigerator at 4 degrees Celsius for later use.

[0134] (4) Construction of rare earth upconversion fluorescence resonance energy transfer system and its application in thrombin detection

[0135] EP tubes containing UCPs-nucleic acid aptamer conjugates (5 μg / mL) were arranged in parallel, and then 0, 2, 4, 6, 8, 10, and 15 μg / mL of polydopamine were added. Finally, the volume was fixed to 1.0 ml with HEPES buffer (50 mM, pH: 7.4). After thorough mixing and shaking incubation, the upconversion fluorescence quenching spectrum was measured to determine that the polydopamine concentration at the maximum quenching efficiency was 10 μg / ml. Furthermore, UCPs-aptamer conjugates (5 μg / mL) and polydopamine 10 μg / ml were prepared in parallel, and then a series of thrombin solutions with concentrations of 0, 0.2, 0.5, 1, 2, 5, 10, 15, and 20 nM were added. Finally, the volume was fixed to 1.0 ml with HEPES buffer (50 mM, pH: 7.4), mixed thoroughly, and incubated with shaking. The upconversion fluorescence recovery spectrum was measured, and a working curve between the thrombin concentration and the luminescence intensity at the strongest emission wavelength of UCPs was established. It was found that the thrombin concentration had a good linear relationship in the range of 0.2-10 nM, and the detection limit was 0.037 nM.

[0136] In addition, the inventor of this case also used other raw materials and other process conditions listed above to replace various raw materials and corresponding process conditions in the embodiments to conduct corresponding experiments, and the results obtained were basically similar to those in the embodiments. Therefore, the verification contents of each embodiment will not be described one by one here, and only the above embodiments are used as representatives to illustrate the excellence of the present invention.

[0137] It should be understood that the above embodiments are only for illustrating the technical concept and features of the present invention, and their purpose is to enable people familiar with the technology to understand the content of the present invention and implement it accordingly, and they cannot be used to limit the protection scope of the present invention. Any equivalent changes or modifications made according to the spirit of the present invention should be included in the protection scope of the present invention. Sequence Listing <110> Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences <120> A rare earth upconversion energy transfer nanosensing platform, construction method and application <160> 6 <170> SIPOSequenceListing 1.0 <210> 1 <211> 40 <212> DNA <213> Artificial sequence (artificial sequence) <400> 1 acttcagtga gttgtcccac ggtcggcgag tcggtggtag 40 <210> 2 <211> 74 <212> DNA <213> Artificial sequence (artificial sequence) <400> 2 gcatcactac agtcattacg catcgggtaa gcggaactga ggagtggggag gtaaatcgtg 60 tgaagtgctg tccc 74 <210> 3 <211> 36 <212> DNA <213> Artificial sequence (artificial sequence) <400> 3 gatcgggtgt gggtggcgta aagggagcat cggaca 36 <210> 4 <211> 27 <212> DNA <213> Artificial sequence (artificial sequence) <400> 4 acctggggga gtattgcgga ggaaggt 27 <210> 5 <211> 32 <212> DNA <213> Artificial sequence (artificial sequence) <400> 5 ctctcttctc ttcatttttc aacacaacac ac 32 <210> 6 <211> 17 <212> DNA <213> Artificial sequence (artificial sequence) <400> 6 acggttggtg tggttgg 17

Claims

1. Application of a rare earth upconversion energy transfer nanosensing platform in silver ion detection, characterized in that: The rare earth upconversion energy transfer nanosensing platform comprises: Amino-modified single-stranded nucleic acid aptamer; A fluorescent donor material, one end of the amino-modified single-stranded nucleic acid aptamer is covalently modified on the surface of the fluorescent donor material; A fluorescent acceptor material, wherein a fluorescent donor material modified with an amino-modified single-stranded nucleic acid aptamer is assembled on the surface of the fluorescent acceptor material through π-π interaction; The fluorescent donor material is rare earth up-conversion luminescent nanoparticles with a particle size of 60 nm; the fluorescent acceptor material is polydopamine nanoparticles with a particle size of 200 nm; the mass ratio of the fluorescent donor material to the fluorescent acceptor material is 1:10; the molar ratio of the fluorescent donor material to the amino-modified single-stranded nucleic acid aptamer is 1000:1-5000:1; The applications include: Weigh 5 mg of PAA-UCPs and dissolve it in 1 ml of MES buffer solution, then add 10 mg of EDC·HCl and 15 mg of Sulfo-NHS to activate the carboxyl group, shake and react at room temperature for 30 minutes, then adjust the pH of the reaction solution to 7.4 with a dilute NaOH solution, add 1 OD of Ag(I) nucleic acid aptamer, react for 4 hours, centrifuge, wash with water once, and finally store in HEPES buffer solution and place in a refrigerator at 4 degrees Celsius for use; Weigh 0.2 g dopamine and dissolve it in 4 ml water, then quickly add it to a mixed solvent containing concentrated ammonia, ethanol and water, stir vigorously, react at room temperature for 12 hours, then centrifuge, wash with water 3 times, dissolve in water and place in a refrigerator at 4 degrees Celsius for later use; Prepare in parallel 5 μg / mL of UCPs-aptamer conjugate and 8 μg / mL of polydopamine, then add a series of concentrations of Ag(I) solution, dilute to 1.0 mL with HEPES buffer, mix thoroughly, shake and incubate, measure the upconversion fluorescence recovery spectrum, and establish a working curve between Ag(I) concentration and the luminescence intensity at the strongest emission wavelength of UCPs; The sequence of the Ag(I) nucleic acid aptamer is: 5'-NH2-C6-CTCTCTTCTCTTCATTTTTCAACACAACACAC-3'; the concentration of Ag(I) is 5.0-75 nM.